Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Alpha Cognition Inc. (ACOG : NSDQ)

• Company Description    Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia. Number of Employees: 71

• Price / Volume Information    Yesterday's Closing Price: $9.13 Daily Weekly Monthly 20 Day Moving Average: 170,193 shares Shares Outstanding: 21.78 (millions) Market Capitalization: $198.83 (millions) Beta: 2.32 52 Week High: $10.14 52 Week Low: $4.50 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 2.01% 3.51% 12 Week 36.68% 32.81% Year To Date 40.46% 25.92%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 1452 Hughes Rd. Ste. 200 - Grapevine,TX 76051 CAN ph: 858-344-4375 fax: - ir@alphacognition.com http://www.alphacognition.com

• General Corporate Information    Officers Michael McFadden - Chief Executive Officer and Director Henry Du - Vice President of Finance and Accounting and inter Len Mertz - Director Kenneth Cawkell - Director Robert Wills - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 02074J501 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/12/26 Share - Related Items Shares Outstanding: 21.78 Most Recent Split Date: 11.00 (0.04:1) Beta: 2.32 Market Capitalization: $198.83 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.33 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.38 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.75 Price/Cash Flow: - Price / Sales: 13.03 EPS Growth vs. Year Ago Period: 38.46% vs. Previous Quarter: -8.11% Sales Growth vs. Year Ago Period: 267.49% vs. Previous Quarter: 72.41% ROE 06/30/26 - -54.60 03/31/26 - -64.44 12/31/25 - -60.27 ROA 06/30/26 - -43.47 03/31/26 - -49.81 12/31/25 - -46.39 Current Ratio 06/30/26 - 9.03 03/31/26 - 12.64 12/31/25 - 8.65 Quick Ratio 06/30/26 - 8.04 03/31/26 - 11.52 12/31/25 - 8.09 Operating Margin 06/30/26 - -185.01 03/31/26 - -276.49 12/31/25 - -249.35 Net Margin 06/30/26 - -153.61 03/31/26 - -232.23 12/31/25 - -202.23 Pre-Tax Margin 06/30/26 - -137.70 03/31/26 - -234.83 12/31/25 - -202.25 Book Value 06/30/26 - 2.43 03/31/26 - 2.64 12/31/25 - 2.88 Inventory Turnover 06/30/26 - 0.27 03/31/26 - 0.33 12/31/25 - 0.67 Debt-to-Equity 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - 0.00 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©